AGT and atrial fibrillation: In order to elucidate the molecular mechanism of reducing myocardial fibrosis and treating AF with vericiguat, transcriptome sequencing was conducted on CFs derived from the blank group, the AngII group, and the vericiguat + AngII treatment group, respectively.